<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lederman, Lynne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Arun, Banu</style></author><author><style face="normal" font="default" size="100%">Antoniou, Antonis C.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Most Genes Associated With Increased Risk of BC Remain Poorly Characterized</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">28-29</style></pages><abstract><style  face="normal" font="default" size="100%">BRCA1 and BRCA2 mutations are clearly associated with an increased risk of breast cancer; increased screening and surgery are important for management, but the role of chemoprevention is unclear. Other genes contribute to breast cancer risk, although most remain unidentified. Enrollment of patients into screening and prevention trials is needed to advance the field.</style></abstract><number><style face="normal" font="default" size="100%">56</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>